These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38105089)

  • 21. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
    Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F
    Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRIgRT dynamic lung motion thorax anthropomorphic QA phantom: Design, development, reproducibility, and feasibility study.
    Steinmann A; Alvarez P; Lee H; Court L; Stafford R; Sawakuchi G; Wen Z; Fuller C; Followill D
    Med Phys; 2019 Nov; 46(11):5124-5133. PubMed ID: 31506963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a 4D-MRI guided liver stereotactic body radiation therapy strategy for implementation on the MR-linac.
    van de Lindt TN; Fast MF; van den Wollenberg W; Kaas J; Betgen A; Nowee ME; Jansen EP; Schneider C; van der Heide UA; Sonke JJ
    Phys Med Biol; 2021 May; 66(10):. PubMed ID: 33887708
    [No Abstract]   [Full Text] [Related]  

  • 24. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRgRT Quality Assurance for a Low-Field MR-Linac.
    Kim JP
    Semin Radiat Oncol; 2024 Jan; 34(1):129-134. PubMed ID: 38105087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of MR-Linac in tumor radiotherapy: a systematic review.
    Liu X; Li Z; Yin Y
    Radiat Oncol; 2023 Mar; 18(1):52. PubMed ID: 36918884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
    Bainbridge HE; Menten MJ; Fast MF; Nill S; Oelfke U; McDonald F
    Radiother Oncol; 2017 Nov; 125(2):280-285. PubMed ID: 28987747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing.
    Westley RL; Valle LF; Tree AC; Kishan AU
    Semin Radiat Oncol; 2024 Jan; 34(1):45-55. PubMed ID: 38105093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance procedure for the linear accelerator component of the 1.5 T MRI-linac.
    Woodings SJ; de Vries JHW; Kok JMG; Hackett SL; van Asselen B; Bluemink JJ; van Zijp HM; van Soest TL; Roberts DA; Lagendijk JJW; Raaymakers BW; Wolthaus JWH
    J Appl Clin Med Phys; 2021 Aug; 22(8):45-59. PubMed ID: 34275176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features.
    Guerini AE; Nici S; Magrini SM; Riga S; Toraci C; Pegurri L; Facheris G; Cozzaglio C; Farina D; Liserre R; Gasparotti R; Ravanelli M; Rondi P; Spiazzi L; Buglione M
    Technol Cancer Res Treat; 2023; 22():15330338231199286. PubMed ID: 37774771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: First 6 months of operation using adapt to shape workflow.
    de Leon J; Crawford D; Moutrie Z; Alvares S; Hogan L; Pagulayan C; Jelen U; Loo C; Aylward JD; Condon K; Dunkerley N; Heinke MY; Sampaio S; Simon K; Twentyman T; Jameson MG
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):138-145. PubMed ID: 34643065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
    Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
    J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI commissioning of 1.5T MR-linac systems - a multi-institutional study.
    Tijssen RHN; Philippens MEP; Paulson ES; Glitzner M; Chugh B; Wetscherek A; Dubec M; Wang J; van der Heide UA
    Radiother Oncol; 2019 Mar; 132():114-120. PubMed ID: 30825959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Old dogs, new tricks: MR-Linac training and credentialing of radiation oncologists, radiation therapists and medical physicists.
    Hogan L; Jameson M; Crawford D; Alvares S; Loo C; Picton M; Moutrie Z; Pagulayan C; Jelen U; Dunkerley N; Twentyman T; de Leon J; Batumalai V
    J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):99-106. PubMed ID: 36502538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of radiation therapist-led adaptive treatments on a 1.5 T MR-Linac.
    Picton M; Crawford D; Jameson M; Alvares S; Hogan L; Loo C; Moutrie Z; Jelen U; Pagulayan C; Dunkerley N; Twentyman T; de Leon J; Batumalai V
    J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):94-98. PubMed ID: 36572532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of magnetic resonance image-guided radiotherapy for breast cancer: a scoping review.
    Berlangieri A; Elliott S; Wasiak J; Chao M; Foroudi F
    J Med Radiat Sci; 2022 Mar; 69(1):122-133. PubMed ID: 34523823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment.
    Raaymakers BW; Jürgenliemk-Schulz IM; Bol GH; Glitzner M; Kotte ANTJ; van Asselen B; de Boer JCJ; Bluemink JJ; Hackett SL; Moerland MA; Woodings SJ; Wolthaus JWH; van Zijp HM; Philippens MEP; Tijssen R; Kok JGM; de Groot-van Breugel EN; Kiekebosch I; Meijers LTC; Nomden CN; Sikkes GG; Doornaert PAH; Eppinga WSC; Kasperts N; Kerkmeijer LGW; Tersteeg JHA; Brown KJ; Pais B; Woodhead P; Lagendijk JJW
    Phys Med Biol; 2017 Nov; 62(23):L41-L50. PubMed ID: 29135471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
    Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
    J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical Note: Comparison of peripheral patient dose from MR-guided
    Hauri P; Hälg RA; Schneider U
    Med Phys; 2017 Jul; 44(7):3788-3793. PubMed ID: 28437010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.